Rand Wealth LLC maintained its stake in Stryker Corp. (NYSE:SYK) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,220 shares of the medical technology company’s stock at the end of the third quarter. Rand Wealth LLC’s holdings in Stryker Corp. were worth $1,655,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Girard Partners LTD. increased its position in shares of Stryker Corp. by 23.8% in the third quarter. Girard Partners LTD. now owns 11,858 shares of the medical technology company’s stock worth $1,380,000 after buying an additional 2,280 shares during the last quarter. Daiwa Securities Group Inc. increased its position in shares of Stryker Corp. by 6.8% in the third quarter. Daiwa Securities Group Inc. now owns 51,600 shares of the medical technology company’s stock worth $6,007,000 after buying an additional 3,300 shares during the last quarter. GVO Asset Management Ltd increased its position in shares of Stryker Corp. by 69.8% in the third quarter. GVO Asset Management Ltd now owns 39,490 shares of the medical technology company’s stock worth $4,597,000 after buying an additional 16,240 shares during the last quarter. Pillar Pacific Capital Management LLC increased its position in shares of Stryker Corp. by 1.7% in the third quarter. Pillar Pacific Capital Management LLC now owns 31,320 shares of the medical technology company’s stock worth $3,646,000 after buying an additional 517 shares during the last quarter. Finally, Confluence Investment Management LLC increased its position in shares of Stryker Corp. by 5.5% in the third quarter. Confluence Investment Management LLC now owns 554,834 shares of the medical technology company’s stock worth $64,588,000 after buying an additional 29,159 shares during the last quarter. 74.90% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Stryker Corp. (NYSE:SYK)

Stryker Corp. (NYSE:SYK) traded down 1.52% during trading on Wednesday, reaching $113.66. The company’s stock had a trading volume of 1,844,255 shares. The firm has a market capitalization of $42.56 billion, a P/E ratio of 25.87 and a beta of 0.86. Stryker Corp. has a one year low of $86.68 and a one year high of $123.55. The stock has a 50-day moving average of $113.43 and a 200 day moving average of $115.08.

Stryker Corp. (NYSE:SYK) last issued its earnings results on Thursday, October 27th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.02. Stryker Corp. had a return on equity of 23.61% and a net margin of 15.24%. The firm had revenue of $2.83 billion for the quarter, compared to the consensus estimate of $2.81 billion. During the same quarter in the prior year, the business earned $1.25 earnings per share. The company’s revenue was up 17.1% compared to the same quarter last year. On average, equities research analysts predict that Stryker Corp. will post $5.78 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Rand Wealth LLC Has $1,655,000 Position in Stryker Corp. (SYK)” was originally published by Financial Market News and is owned by of Financial Market News. If you are reading this piece on another site, it was stolen and republished in violation of United States & international copyright legislation. The correct version of this piece can be read at http://www.financial-market-news.com/rand-wealth-llc-has-1655000-position-in-stryker-corp-syk/1211458/.

A number of research analysts have recently issued reports on the company. Zacks Investment Research downgraded Stryker Corp. from a “buy” rating to a “hold” rating in a report on Monday, November 14th. SunTrust Banks Inc. began coverage on Stryker Corp. in a research report on Thursday, October 13th. They set a “buy” rating and a $140.00 price objective for the company. BMO Capital Markets upgraded Stryker Corp. from an “underperform” rating to a “market perform” rating and set a $125.00 price objective for the company in a research report on Tuesday, November 1st. They noted that the move was a valuation call. Oppenheimer Holdings Inc. set a $122.00 price objective on Stryker Corp. and gave the company a “hold” rating in a research report on Sunday, October 30th. Finally, Canaccord Genuity set a $127.00 price objective on Stryker Corp. and gave the company a “buy” rating in a research report on Sunday, October 30th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $122.38.

In related news, Director Ronda E. Stryker sold 12,000 shares of the company’s stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $115.16, for a total value of $1,381,920.00. Following the completion of the transaction, the director now owns 193,142 shares of the company’s stock, valued at approximately $22,242,232.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 6,000 shares of the company’s stock in a transaction dated Tuesday, November 29th. The stock was sold at an average price of $115.79, for a total value of $694,740.00. Following the completion of the transaction, the director now directly owns 193,142 shares of the company’s stock, valued at approximately $22,363,912.18. The disclosure for this sale can be found here. 7.80% of the stock is owned by insiders.

About Stryker Corp.

Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties.

5 Day Chart for NYSE:SYK

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corp. (NYSE:SYK).

Receive News & Ratings for Stryker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.